Microsoft word - classificationsgrouporder.doc

Agents Classified by the IARC Monographs, Volumes 1–103
Acetaldehyde associated with consumption of alcoholic 000313-67-7 (NB: Overall evaluation upgraded to Group 1 based on 000313-67-7 Aristolochic acid, plants containing 007440-38-2 Arsenic and inorganic arsenic compounds 001332-21-4 013768-00-8 Asbestos (all forms, including actinolite, amosite, 012172-73-5 anthophyllite, chrysotile, crocidolite, tremolite) 017068-78-9 (NB: Mineral substances (e.g. talc or vermiculite) that 012001-29-5 contain asbestos should also be regarded as 012001-28-4 carcinogenic to humans.) 014567-73-8 (NB: Overall evaluation upgraded to Group 1 based on 000050-32-8 (NB: Overall evaluation upgraded to Group 1 based on 007440-41-7 Beryllium and beryllium compounds 000542-88-1 Bis(chloromethyl)ether; chloromethyl methyl ether 007440-43-9 Cadmium and cadmium compounds Clonorchis sinensis (infection with) Coal, indoor emissions from household combustion of Estrogen-progestogen menopausal therapy (combined) Estrogen-progestogen oral contraceptives (combined) (NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary) 000064-17-5 Ethanol in alcoholic beverages 000075-21-8 (NB: Overall evaluation upgraded to Group 1 based on 033419-42-0 (NB: Overall evaluation upgraded to Group 1 based on 033419-42-0 015663-27-1 Etoposide in combination with cisplatin and bleomycin Fission products, including strontium-90 Helicobacter pylori (infection with) Hepatitis B virus (chronic infection with) Hepatitis C virus (chronic infection with) Human immunodeficiency virus type 1 (infection with) Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, (NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer) Iron and steel founding (occupational exposure during) Isopropyl alcohol manufacture using strong acids Methoxsalen (8-methoxypsoralen) plus ultraviolet A 4,4'-Methylenebis(2-chloroaniline) (MOCA) 000101-14-4 (NB: Overall evaluation upgraded to Group 1 based on Mineral oils, untreated or mildly treated MOPP and other combined chemotherapy including (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) N'-Nitrosonornicotine (NNN) and 4-(N- 016543-55-8 Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) 064091-91-4 (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data) Opisthorchis viverrini (infection with) 3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126) 057465-28-8 (NB: Overall evaluation upgraded to Group 1 based on 057117-31-4 (NB: Overall evaluation upgraded to Group 1 based on 000062-44-2 (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) Phenacetin, analgesic mixtures containing Radionuclides, alpha-particle-emitting, internally (NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents) Radionuclides, beta-particle-emitting, internally deposited (NB: Specific radionuclides for which there is evidence in humans are also listed individually as Group 1 agents) 013233-32-4 Radium-224 and its decay products 013982-63-3 Radium-226 and its decay products 015262-20-1 Radium-228 and its decay products 010043-92-2 Radon-222 and its decay products Schistosoma haematobium (infection with) Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1- 014808-60-7 Silica dust, crystalline, in the form of quartz or cristobalite Soot (as found in occupational exposure of chimney (NB: There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients) 001746-01-6 2,3,7,8-Tetrachlorodibenzo-para-dioxin 1 007440-29-1 Thorium-232 and its decay products Ultraviolet radiation (wavelengths 100-400 nm, 000079-06-1 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 023214-92-8 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Art glass, glass containers and pressed ware 000320-67-2 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Biomass fuel (primarily wood), indoor emissions from 000154-93-8 Bischloroethyl nitrosourea (BCNU) 064742-93-4 Bitumens, oxidized, and their emissions during roofing 002425-06-1 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000056-75-7 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000098-87-3 alpha-Chlorinated toluenes (benzal chloride, 000098-07-7 benzotrichloride, benzyl chloride) and benzoyl chloride 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) 013010-47-4 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000095-69-2 4-Chloro-ortho-toluidine 2A 054749-90-5 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 015663-27-1 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 007440-48-4 Cobalt metal with tungsten carbide 027208-37-3 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000224-42-0 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000053-70-3 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000191-30-0 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000064-67-5 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000079-44-7 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000540-73-8 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000077-78-1 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000106-89-8 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000106-93-4 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000759-73-9 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Frying, emissions from high-temperature 000556-52-5 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Hairdresser or barber (occupational exposure as a) (NB: Overall evaluation upgraded to Group 2A) IQ (2-Amino-3-methylimidazo[4,5-f]quinoline) 076180-96-6 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000484-20-8 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000066-27-3 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) N-Methyl-N´-nitro-N-nitrosoguanidine (MNNG) 000070-25-7 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000684-93-5 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Nitrate or nitrite (ingested) under conditions that result in 000055-18-5 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000062-75-9 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000088-72-2 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Non-arsenical insecticides (occupational exposures in Petroleum refining (occupational exposures in) 000366-70-1 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) Shiftwork that involves circadian disruption 000096-09-3 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 029767-20-2 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) 000127-18-4 Tetrachloroethylene (Perchloroethylene) 000126-72-7 (NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data) (NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride.) (NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride.) 026148-68-5 A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) 003688-53-7 AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide] 000097-56-3 ortho-Aminoazotoluene 000081-49-2 1-Amino-2,4-dibromoanthraquinone 000712-68-5 2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole 000151-56-4 (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 000202-33-5 (NB: Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data) 000205-99-2 Benzo[b]fluoranthene 2B 000205-82-3 Benzo[j]fluoranthene 2B 000207-08-9 Benzo[k]fluoranthene 2B 000195-19-7 (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 003296-90-0 2,2-Bis(bromomethyl)propane-1,3-diol Bitumens, extracts of steam-refined and air-refined 008052-42-4 (see Bitumens, oxidized; Bitumens, hard; Bitumens, Bitumens, hard, and their emissions during mastic 008052-42-4 Bitumens, straight-run, and their emissions during road- 011056-06-7 (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 005589-96-8 Bromochloroacetic acid 025013-16-5 Butylated hydroxyanisole (BHA) 053973-98-1 Carrageenan, degraded (Poligeenan) Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60% 000106-47-8 para-Chloroaniline 2B 077439-76-0 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone 2B 000095-83-0 4-Chloro-ortho-phenylenediamine 007440-48-4 Cobalt metal without tungsten carbide 010026-24-1 Cobalt sulfate and other soluble cobalt(II) salts 068603-42-9 Coconut oil diethanolamine condensate (NB: There is some evidence of an inverse relationship between coffee drinking and cancer of the large bowel; coffee drinking could not be classified as to its carcinogenicity to other organs) 000117-10-2 Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) 000050-29-3 DDT (4,4'-Dichlorodiphenyltrichloroethane) 000613-35-4 N,N'-Diacetylbenzidine 000226-36-8 Dibenz[a,h]acridine 2B 000224-53-3 (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 000194-59-2 7H-Dibenzo[c,g]carbazole 2B 000189-64-0 Dibenzo[a,h]pyrene 2B 000189-55-9 Dibenzo[a,i]pyrene 2B 000106-46-7 para-Dichlorobenzene 2B 028434-86-8 3,3'-Dichloro-4,4'-diaminodiphenyl ether 000075-09-2 Dichloromethane (Methylene chloride) 000542-75-6 1,3-Dichloropropene (technical-grade) (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 000119-90-4 3,3'-Dimethoxybenzidine (ortho-Dianisidine) 000060-11-7 para-Dimethylaminoazobenzene 025962-77-0 trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2- 000087-62-7 2,6-Dimethylaniline (2,6-Xylidine) 000119-93-7 3,3'-Dimethylbenzidine (ortho-Tolidine) Dry cleaning (occupational exposures in) 000106-88-7 (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) Firefighter (occupational exposure as a) 003570-75-0 2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole 116355-83-0 Fusarium moniliforme, toxins derived from (fumonisin B1, (NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data) 067730-10-3 Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole) Human immunodeficiency virus type 2 (infection with) Human papillomavirus types 5 and 8 (in patients with Human papillomavirus types 26, 53, 66, 67, 70, 73, 82 Human papillomavirus types 30, 34, 69, 85, 97 (NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1) 000193-39-5 Indeno[1,2,3-cd]pyrene 2B Magnetic fields, extremely low-frequency 068006-83-7 MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) 077094-11-2 MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) 2B 077500-04-0 MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) 2B 000075-55-8 2-Methylaziridine (Propyleneimine) 000838-88-0 4,4'-Methylene bis(2-methylaniline) 000129-15-7 2-Methyl-1-nitroanthraquinone (uncertain purity) 000615-53-2 N-Methyl-N-nitrosourethane 000101-61-1 Michler’s base [4,4-methylenebis(N,N-dimethyl)- 000090-94-8 Michler’s ketone [4,4-Bis(dimethylamino)benzophenone] 000096-24-2 3-Monochloro-1,2-propanediol 5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2- 000555-84-0 1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone 000531-82-8 N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide 000126-85-2 Nitrogen mustard N-oxide 000924-16-3 N-Nitrosodi-n-butylamine 001116-54-7 N-Nitrosodiethanolamine 000621-64-7 N-Nitrosodi-n-propylamine 060153-49-3 3-(N-Nitrosomethylamino)propionitrile 010595-95-6 N-Nitrosomethylethylamine 004549-40-0 N-Nitrosomethylvinylamine 000059-89-2 N-Nitrosomorpholine 000100-75-4 N-Nitrosopiperidine 000930-55-2 N-Nitrosopyrrolidine 013256-22-9 N-Nitrososarcosine 012174-11-7 Palygorskite (Attapulgite) (long fibres, > 5 micrometres) 000794-93-4 Panfuran S (containing dihydroxymethylfuratrizine) Pickled vegetables (traditional in Asia) 000136-40-3 Phenazopyridine hydrochloride 000063-92-3 Phenoxybenzamine hydrochloride 105650-23-5 PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) 2B Polychlorophenols and their sodium salts (mixed Printing processes (occupational exposures in) Radiofrequency electromagnetic fields1 2B Schistosoma japonicum (infection with) 000132-27-4 Sodium ortho-phenylphenate 2B Special-purpose fibres such as E-glass and '475' glass 1 Includes radiofrequency electromagnetic fields from wireless phones Surgical implants and other foreign bodies: - Polymeric implants prepared as thin smooth film (with the exception of poly(glycolic acid)) - Metallic implants prepared as thin smooth films - Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium and 7% iron 014807-96-6 Talc-based body powder (perineal use of) Textile manufacturing industry (work in) 008001-35-2 Toxaphene (Polychlorinated camphenes) 000817-09-4 Trichlormethine (Trimustine hydrochloride) 062450-06-0 Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole) 062450-07-1 Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole) 000106-87-6 4-Vinylcyclohexene diepoxide (NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders) 025732-74-5 Acepyrene (3,4-dihydrocyclopenta[cd]pyrene) 3 Acrylonitrile-butadiene-styrene copolymers 000150-13-0 para-Aminobenzoic acid 000082-28-0 1-Amino-2-methylanthraquinone 000061-82-5 (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) 000523-50-2 Angelicin plus ultraviolet A radiation Arsenobetaine and other organic arsenic compounds that 001912-24-9 (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) 000202-94-8 11H-Benz[bc]aceanthrylene 3 000211-91-6 Benz[l]aceanthrylene 3 000203-33-8 Benzo[a]fluoranthene 3 000203-12-3 Benzo[ghi]fluoranthene 3 000239-35-0 Benzo[b]naphtho[2,1-d]thiophene 3 000105-11-3 para-Benzoquinone dioxime 002168-68-5 Bis(1-aziridinyl)morpholinophosphine sulfide 000111-44-4 Bis(2-chloroethyl)ether 013483-18-6 1,2-Bis(chloromethoxy)ethane 056894-91-8 1,4-Bis(chloromethoxymethyl)benzene 000108-60-1 Bis(2-chloro-1-methylethyl)ether 002386-90-5 Bis(2,3-epoxycyclopentyl)ether 001675-54-3 Bisphenol A diglycidyl ether (Araldite ) 3 Bitumens, steam-refined, cracking-residue and air-refined 008052-42-4 (see Bitumens, oxidized; Bitumens, hard; Bitumens, 003844-45-9 Brilliant Blue FCF, disodium salt 057018-52-7 1-tert-Butoxypropan-2-ol 3 000128-37-0 Butylated hydroxytoluene (BHT) 000088-73-3 000121-73-3 Chloronitrobenzenes 3 000100-00-5 005131-60-2 4-Chloro-meta-phenylenediamine 000095-79-4 5-Chloro-ortho-toluidine 3 000075-88-7 2-Chloro-1,1,1-trifluoroethane 000102-50-1 meta-Cresidine 000139-05-9 Cyclamates (sodium cyclamate) 000202-98-2 4H-Cyclopenta[def]chrysene 3 007099-43-6 5,6-Cyclopenteno-1,2-benzanthracene 001163-19-5 Decabromodiphenyl oxide 000083-63-6 Diacetylaminoazotoluene 000215-58-7 Dibenz[a,c]anthracene 3 000224-41-9 Dibenz[a,j]anthracene 3 000262-12-4 Dibenzo-para-dioxin 3 005385-75-1 Dibenzo[a,e]fluoranthene 3 000207-83-0 13H-Dibenzo[a,g]fluorene 3 000192-47-2 Dibenzo[h,rst]pentaphene 3 000541-73-1 meta-Dichlorobenzene 3 000095-50-1 ortho-Dichlorobenzene 3 000110-57-6 trans-1,4-Dichlorobutene 000609-20-1 2,6-Dichloro-para-phenylenediamine 000105-55-5 N,N'-Diethylthiourea 3 000794-93-4 Dihydroxymethylfuratrizine (see also Panfuran S) 000091-93-0 3,3'-Dimethoxybenzidine-4,4'-diisocyanate 000140-56-7 para-Dimethylaminoazobenzenediazo sodium sulfonate 022975-76-4 4,4'-Dimethylangelicin plus ultraviolet A radiation 004063-41-6 4,5'-Dimethylangelicin plus ultraviolet A radiation 000121-69-7 N,N-Dimethylaniline 3 000101-25-7 Dinitrosopentamethylenetetramine Electric fields, extremely low-frequency 3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6- 002443-39-2 cis-9,10-Epoxystearic acid 000096-45-7 (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) Flat-glass and specialty glass (manufacture of) 016984-48-8 Fluorides (inorganic, used in drinking-water) Fusarium graminearum, F. culmorum, and F. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X) Fusarium sporotrichioides, toxins derived from (T-2 toxin) Hair colouring products (personal use of) Human papillomavirus genus beta (except types 5 and 8) Human T-cell lymphotropic virus type II 001338-16-5 Iron sorbitol-citric acid complex 000054-85-3 Isonicotinic acid hydrazide (Isoniazid) (NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead.) 005989-27-5 (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) Lumber and sawmill industries (including logging) 000551-74-6 Mannomustine dihydrochloride 000108-78-1 (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) 007439-97-6 Mercury and inorganic mercury compounds 073459-03-7 5-Methylangelicin plus ultraviolet A radiation 001634-04-4 Methyl tert-butyl ether 000099-80-9 N-Methyl-N,4-dinitrosoaniline 000101-68-8 4,4'-Methylenediphenyl diisocyanate 090456-67-0 N-Methylolacrylamide 3 085878-63-3 7-Methylpyrido[3,4-c]psoralen 003173-72-6 1,5-Naphthalene diisocyanate 111189-32-3 Naphtho[1,2-b]fluoranthene 3 000203-20-3 Naphtho[2,1-a]fluoranthene 3 000193-09-9 Naphtho[2,3-e]pyrene 3 000086-88-4 1-Naphthylthiourea (ANTU) 000099-59-2 5-Nitro-ortho-anisidine 020268-51-3 7-Nitrobenz[a]anthracene 3 063041-90-7 6-Nitrobenzo[a]pyrene 3 037620-20-5 N'-Nitrosoanabasine (NAB) 071267-22-6 N'-Nitrosoanatabine (NAT) 000086-30-6 N-Nitrosodiphenylamine 000156-10-5 para-Nitrosodiphenylamine 055557-02-3 N-Nitrosoguvacoline 3 030310-80-6 N-Nitrosohydroxyproline 085502-23-4 3-(N-Nitrosomethylamino)propionaldehyde 3 007519-36-0 N-Nitrosoproline 000099-99-0 000099-55-8 5-Nitro-ortho-toluidine 3 Opisthorchis felineus (infection with) Paint manufacture (occupational exposure in) 012174-11-7 Palygorskite (Attapulgite)(short fibres, < 5 micrometres) 000108-45-2 meta-Phenylenediamine 000106-50-3 para-Phenylenediamine 000135-88-6 N-Phenyl-2-naphthylamine 009016-87-9 Polymethylene polyphenyl isocyanate 023746-34-1 Potassium bis(2-hydroxyethyl)dithiocarbamate 085878-62-2 Pyrido[3,4-c]psoralen 000082-68-8 Quintozene (Pentachloronitrobenzene) 000081-07-2 (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) Schistosoma mansoni (infection with) 007782-49-2 Selenium and selenium compounds 000148-18-5 Sodium diethyldithiocarbamate 009003-54-7 Styrene-acrylonitrile copolymers 009003-55-8 Styrene-butadiene copolymers 000127-69-5 Sulfafurazole (Sulfisoxazole) 000057-68-1 (NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data) Surgical implants and other foreign bodies: - Organic polymeric materials (as a group) - Orthopaedic implants of complex composition - Cardiac pacemakers - Silicone breast implants - Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based and titanium-based alloys, stainless steel and depleted uranium - Dental materials - Ceramic implants 014807-96-6 Talc not containing asbestos or asbestiform fibres 008001-50-1 Terpene polychlorinates (Strobane®) 015721-02-5 2,2',5,5'-Tetrachlorobenzidine Tetrakis(hydroxymethyl)phosphonium salts 001954-28-5 Triethylene glycol diglycidyl ether 090370-29-9 4,4',6-Trimethylangelicin plus ultraviolet A radiation 000068-76-8 Tris(aziridinyl)-para-benzoquinone (Triaziquone) 000545-55-1 Tris(1-aziridinyl)phosphine oxide 000051-18-3 2,4,6-Tris(1-aziridinyl)-s-triazine 000115-96-8 Tris(2-chloroethyl) phosphate 038571-73-2 1,2,3-Tris(chloromethoxy)propane 000057-39-6 Tris(2-methyl-1-aziridinyl)phosphine oxide 009003-22-9 Vinyl chloride-vinyl acetate copolymers 009011-06-7 Vinylidene chloride-vinyl chloride copolymers 000088-12-0 N-Vinyl-2-pyrrolidone Zeolites other than erionite (clinoptilolite, 001318-02-1 phillipsite,mordenite, non-fibrous Japanese zeolite, 000103-90-2 Acetaminophen (see Paracetamol) 012174-11-7 Attapulgite (see Palygorskite) 000494-03-1 N,N-Bis(2-chloroethyl)-2-naphthylamine (see Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl) Boot and shoe manufacture and repair (see Leather dust, 000055-98-1 1,4-Butanediol dimethanesulfonate (see Busulfan) 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea Chloromethyl methyl ether (see Bis(chloromethyl)ether; 001937-37-7 CI Direct Black 38 (see Benzidine, dyes metabolized to) 002602-46-2 CI Direct Blue 6 (see Benzidine, dyes metabolized to) 016071-86-6 CI Direct Brown 95 (see Benzidine, dyes metabolized to) 059865-13-3 Ciclosporin (see Cyclosporine) 008007-45-2 Coal tars (see Coal-tar distillation) Continuous glass filament (see Glass filament) Diesel engine exhaust (see Engine exhaust, diesel) Dyes metabolized to benzidine (see Benzidine, dyes Foreign bodies (see Surgical implants and other foreign Furniture and cabinet making (see Wood dust) Gallium arsenide (see Arsenic and inorganic arsenic Gamma-Radiation (see X- and Gamma-Radiation) Gasoline engine exhaust (see Engine exhaust, gasoline) Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of) Household combustion of coal (see Coal, indoor Human herpesvirus type 4 (see Epstein-Barr virus) Human herpesvirus type 8 (see Kaposi sarcoma Involuntary smoking (see Tobacco smoke, second-hand) 010043-66-0 Iodine-131 (see Radioiodines) 000505-60-2 Mustard gas (see Sulfur mustard) Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives) 000523-44-4 Orange I (see CI Acid Orange 20) Paving and roofing with coal-tar pitch (see Coal-tar pitch) 000087-86-5 Pentachlorophenol (see Polychlorophenols) 053973-98-1 Poligeenan (see Carrageenan, degraded) Strong-inorganic-acid mists containing sulfuric acid (see 010098-97-2 Strontium-90 (see Fission products) Sunlamps and sunbeds (see Ultraviolet-emitting tanning 014807-96-6 Talc containing asbestiform fibres (see Asbestos) 012070-12-1 Tungsten carbide with cobalt metal (see Cobalt metal Wood smoke (see Biomass fuel, indoor emissions from
Last update: 22 February 2012

Source: http://stlachpin65.free.fr/cours/Projet%20doc%20cancer/Xavier/Sources/Agents%20Classified%20by%20the%20IARC%20Monographs,%20Volumes%201%E2%80%93103.pdf

Microsoft word - laurenherrresume2013.docx

Lauren Herr 1148 Jaland Ct, San Jose, CA 95120 • 408.691.0079 herr.lauren@gmail.com • http://lauren.herr.cc EDUCATION Pepperdine University, Malibu, CA Fall 2009-Spring 2013 Major in Media Production; Minor in Multimedia Design Graduated April 2013 Activities: On-Air Graphics Designer and Operator for weekly live news television show, Newswaves32 (2012-2013), Fashion Bl

Microsoft word _ pa8p050530e_doc

Joint analysis of two Phase II studies with Desmoteplase presented at the European Stroke Conference Confirmatory study DIAS-2 started to confirm 3-9 hour treatment time window Aachen, Bologna, 30 May 2005 – The joint analysis of DIAS and DEDAS, two Phase II studies sponsored by PAION that examined the investigational novel plasminogen activator Desmoteplase in the treatment of acute isc

© 2010-2017 Pharmacy Pills Pdf